Galatek is a Singapore-headquartered automation and artificial intelligence startup focused on the life sciences and semiconductor sectors. Its flagship Abio software platform integrates AI-driven electronic lab notebook (ELN), laboratory information management system (LIMS), scientific data management system (SDMS), and automation controls to create smart laboratories and accelerate R&D workflows. In the semiconductor space, the company offers AI-driven advanced packaging solutions such as automated overlay measurement, deep-learning optical inspection, and precision wafer dicing equipment. Led by CEO David Tian, Galatek positions itself as a reliable infrastructure partner enabling digital transformation in highly technical industries. The firm plans to deploy new capital to develop additional products and broaden its on-the-ground expertise across Europe, North America, and Southeast Asia. No operating metrics such as revenue or user numbers were disclosed. The Series A proceeds represent its first publicly announced institutional raise, providing resources for continued product innovation and global expansion.

Total raised

$30M

Funding rounds

1

Latest round

Series A

Latest activity

Dec 2025